Biotech company Idogen was invited to attend The Guthy Jackson Charitable Foundation's "3rd Summit for NMOSD Tolerization" in Los Angeles on January 20-22. A total of ten companies from Europe and the US were invited, all with the goal of curing autoimmune diseases by restoring immune tolerance. The focus of the event was the autoimmune disease Neuromyelitis Optica Spectrum Disorders (NMOSD).

Read the full article at biostock.se:

https://www.biostock.se/en/2023/02/idogen-one-of-ten-companies-selected-for-field-leading-event/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

https://news.cision.com/idogen/r/biostock-idogen-one-of-ten-companies-selected-for-field-leading-event,c3710078

(c) 2023 Cision. All rights reserved., source Press Releases - English